Penn State’s James Franklin: ‘I’ll take any vaccine they can give me’

GlobeNewswire

Global Wide Field Imaging Devices Market to Reach $716.1 Million by 2027

Abstract: – Global Wide Field Imaging Devices Market to Reach $716. 1 Million by 2027. – Amid the COVID-19 crisis, the global market for Wide Field Imaging Devices estimated at US$491.New York, April 08, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Wide Field Imaging Devices Industry” – https://www.reportlinker.com/p06033303/?utm_source=GNW 7 Million in the year 2020, is projected to reach a revised size of US$716.1 Million by 2027, growing at aCAGR of 5.5% over the period 2020-2027. Table Top, one of the segments analyzed in the report, is projected to record 5.4% CAGR and reach US$476.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hand-Held segment is readjusted to a revised 5.8% CAGR for the next 7-year period. – The U.S. Market is Estimated at $133.2 Million, While China is Forecast to Grow at 8.4% CAGR – The Wide Field Imaging Devices market in the U.S. is estimated at US$133.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$149.4 Million by the year 2027 trailing a CAGR of 8.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR. – Select Competitors (Total 42 Featured) – Carl Zeiss Meditec AGCentervue S.P.A.Clarity Medical Systems, Inc.Epipole Ltd.Forus Health Pvt LtdHeidelberg Engineering Inc.Medibell Medical Vision Technologies LtdoDocs Eye CareOptosPhoenix Technology Group, LLC Read the full report: https://www.reportlinker.com/p06033303/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Wide Field Imaging Devices by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Wide Field Imaging Devices by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Wide Field Imaging Devices by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Table Top by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Table Top by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Table Top by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Hand-Held by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Hand-Held by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Hand-Held by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Hospitals by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Hospitals by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Hospitals by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Specialty Clinics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Specialty Clinics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Specialty Clinics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Ambulatory Surgical Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Other End-Uses by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Other End-Uses by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Other End-Uses by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Diabetic Retinopathy by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Diabetic Retinopathy by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Diabetic Retinopathy by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for Retinopathy of Prematurity by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for Retinopathy of Prematurity by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for Retinopathy of Prematurity by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for Retinal Vein Occlusion by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 29: World Historic Review for Retinal Vein Occlusion by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: World 15-Year Perspective for Retinal Vein Occlusion by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 31: World Current & Future Analysis for Uveitis by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 32: World Historic Review for Uveitis by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: World 15-Year Perspective for Uveitis by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 34: World Current & Future Analysis for Choroidal Melanoma by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 35: World Historic Review for Choroidal Melanoma by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: World 15-Year Perspective for Choroidal Melanoma by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 37: World Current & Future Analysis for Hemoglobinopathy by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 38: World Historic Review for Hemoglobinopathy by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: World 15-Year Perspective for Hemoglobinopathy by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 40: World Current & Future Analysis for Other Applications by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 41: World Historic Review for Other Applications by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: World 15-Year Perspective for Other Applications by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Table 43: USA Current & Future Analysis for Wide Field Imaging Devices by Type – Table Top and Hand-Held – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: USA Historic Review for Wide Field Imaging Devices by Type – Table Top and Hand-Held Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: USA 15-Year Perspective for Wide Field Imaging Devices by Type – Percentage Breakdown of Value Sales for Table Top and Hand-Held for the Years 2012, 2020 & 2027 Table 46: USA Current & Future Analysis for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: USA Historic Review for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: USA 15-Year Perspective for Wide Field Imaging Devices by End-Use – Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2020 & 2027 Table 49: USA Current & Future Analysis for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: USA Historic Review for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: USA 15-Year Perspective for Wide Field Imaging Devices by Application – Percentage Breakdown of Value Sales for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications for the Years 2012, 2020 & 2027 CANADA Table 52: Canada Current & Future Analysis for Wide Field Imaging Devices by Type – Table Top and Hand-Held – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Canada Historic Review for Wide Field Imaging Devices by Type – Table Top and Hand-Held Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Canada 15-Year Perspective for Wide Field Imaging Devices by Type – Percentage Breakdown of Value Sales for Table Top and Hand-Held for the Years 2012, 2020 & 2027 Table 55: Canada Current & Future Analysis for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Canada Historic Review for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Canada 15-Year Perspective for Wide Field Imaging Devices by End-Use – Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2020 & 2027 Table 58: Canada Current & Future Analysis for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Canada Historic Review for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Canada 15-Year Perspective for Wide Field Imaging Devices by Application – Percentage Breakdown of Value Sales for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications for the Years 2012, 2020 & 2027 JAPAN Table 61: Japan Current & Future Analysis for Wide Field Imaging Devices by Type – Table Top and Hand-Held – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: Japan Historic Review for Wide Field Imaging Devices by Type – Table Top and Hand-Held Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: Japan 15-Year Perspective for Wide Field Imaging Devices by Type – Percentage Breakdown of Value Sales for Table Top and Hand-Held for the Years 2012, 2020 & 2027 Table 64: Japan Current & Future Analysis for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: Japan Historic Review for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: Japan 15-Year Perspective for Wide Field Imaging Devices by End-Use – Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2020 & 2027 Table 67: Japan Current & Future Analysis for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: Japan Historic Review for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: Japan 15-Year Perspective for Wide Field Imaging Devices by Application – Percentage Breakdown of Value Sales for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications for the Years 2012, 2020 & 2027 CHINA Table 70: China Current & Future Analysis for Wide Field Imaging Devices by Type – Table Top and Hand-Held – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: China Historic Review for Wide Field Imaging Devices by Type – Table Top and Hand-Held Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: China 15-Year Perspective for Wide Field Imaging Devices by Type – Percentage Breakdown of Value Sales for Table Top and Hand-Held for the Years 2012, 2020 & 2027 Table 73: China Current & Future Analysis for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: China Historic Review for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: China 15-Year Perspective for Wide Field Imaging Devices by End-Use – Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2020 & 2027 Table 76: China Current & Future Analysis for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: China Historic Review for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: China 15-Year Perspective for Wide Field Imaging Devices by Application – Percentage Breakdown of Value Sales for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications for the Years 2012, 2020 & 2027 EUROPE Table 79: Europe Current & Future Analysis for Wide Field Imaging Devices by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 80: Europe Historic Review for Wide Field Imaging Devices by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: Europe 15-Year Perspective for Wide Field Imaging Devices by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 82: Europe Current & Future Analysis for Wide Field Imaging Devices by Type – Table Top and Hand-Held – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: Europe Historic Review for Wide Field Imaging Devices by Type – Table Top and Hand-Held Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: Europe 15-Year Perspective for Wide Field Imaging Devices by Type – Percentage Breakdown of Value Sales for Table Top and Hand-Held for the Years 2012, 2020 & 2027 Table 85: Europe Current & Future Analysis for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: Europe Historic Review for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: Europe 15-Year Perspective for Wide Field Imaging Devices by End-Use – Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2020 & 2027 Table 88: Europe Current & Future Analysis for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: Europe Historic Review for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: Europe 15-Year Perspective for Wide Field Imaging Devices by Application – Percentage Breakdown of Value Sales for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications for the Years 2012, 2020 & 2027 FRANCE Table 91: France Current & Future Analysis for Wide Field Imaging Devices by Type – Table Top and Hand-Held – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: France Historic Review for Wide Field Imaging Devices by Type – Table Top and Hand-Held Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: France 15-Year Perspective for Wide Field Imaging Devices by Type – Percentage Breakdown of Value Sales for Table Top and Hand-Held for the Years 2012, 2020 & 2027 Table 94: France Current & Future Analysis for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: France Historic Review for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: France 15-Year Perspective for Wide Field Imaging Devices by End-Use – Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2020 & 2027 Table 97: France Current & Future Analysis for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: France Historic Review for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 99: France 15-Year Perspective for Wide Field Imaging Devices by Application – Percentage Breakdown of Value Sales for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications for the Years 2012, 2020 & 2027 GERMANY Table 100: Germany Current & Future Analysis for Wide Field Imaging Devices by Type – Table Top and Hand-Held – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 101: Germany Historic Review for Wide Field Imaging Devices by Type – Table Top and Hand-Held Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 102: Germany 15-Year Perspective for Wide Field Imaging Devices by Type – Percentage Breakdown of Value Sales for Table Top and Hand-Held for the Years 2012, 2020 & 2027 Table 103: Germany Current & Future Analysis for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 104: Germany Historic Review for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 105: Germany 15-Year Perspective for Wide Field Imaging Devices by End-Use – Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2020 & 2027 Table 106: Germany Current & Future Analysis for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 107: Germany Historic Review for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 108: Germany 15-Year Perspective for Wide Field Imaging Devices by Application – Percentage Breakdown of Value Sales for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications for the Years 2012, 2020 & 2027 ITALY Table 109: Italy Current & Future Analysis for Wide Field Imaging Devices by Type – Table Top and Hand-Held – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 110: Italy Historic Review for Wide Field Imaging Devices by Type – Table Top and Hand-Held Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 111: Italy 15-Year Perspective for Wide Field Imaging Devices by Type – Percentage Breakdown of Value Sales for Table Top and Hand-Held for the Years 2012, 2020 & 2027 Table 112: Italy Current & Future Analysis for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 113: Italy Historic Review for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 114: Italy 15-Year Perspective for Wide Field Imaging Devices by End-Use – Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses for the Years 2012, 2020 & 2027 Table 115: Italy Current & Future Analysis for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 116: Italy Historic Review for Wide Field Imaging Devices by Application – Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 117: Italy 15-Year Perspective for Wide Field Imaging Devices by Application – Percentage Breakdown of Value Sales for Diabetic Retinopathy, Retinopathy of Prematurity, Retinal Vein Occlusion, Uveitis, Choroidal Melanoma, Hemoglobinopathy and Other Applications for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 118: UK Current & Future Analysis for Wide Field Imaging Devices by Type – Table Top and Hand-Held – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 119: UK Historic Review for Wide Field Imaging Devices by Type – Table Top and Hand-Held Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 120: UK 15-Year Perspective for Wide Field Imaging Devices by Type – Percentage Breakdown of Value Sales for Table Top and Hand-Held for the Years 2012, 2020 & 2027 Table 121: UK Current & Future Analysis for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 122: UK Historic Review for Wide Field Imaging Devices by End-Use – Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 123: UK 15-Year Perspective for Wide Field Imaging Devices by End-Use – Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p06033303/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001